Group 1 - The Rosen Law Firm is reminding sellers of Masonite International Corporation common stock about a class action lawsuit with a lead plaintiff deadline of April 7, 2026 [1][2] - Investors who sold Masonite common stock between June 5, 2023, and February 8, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][4] - The lawsuit alleges that defendants made material omissions and misrepresentations regarding Owens Corning's offers to purchase Masonite's stock at significant premiums, which could have indicated a higher value for Masonite's stock [4] Group 2 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Beyond Meat, Inc. securities between February 27, 2025, and November 11, 2025, of the March 24, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Beyond Meat securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit alleges that Beyond Meat made materially false and misleading statements regarding its long-lived assets and their fair value, which could lead to a significant non-cash impairment charge [5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements in recovering substantial amounts for investors [4]. - The firm has been recognized for its success in securities class action settlements, including being ranked No. 1 for the number of settlements in 2017 and securing over $438 million for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Investors who purchased PennyMac securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees, as the Rosen Law Firm is preparing to seek recovery of investor losses [2]. - Interested investors can join the prospective class action by submitting a form or contacting the firm directly for more information [2]. Group 2: Financial Performance and Stock Impact - On January 29, 2026, PennyMac reported its fourth quarter and full-year 2025 financial results, revealing a significant decline in its servicing segment pretax income to $37.3 million, down from $157.4 million in the prior quarter and $87.3 million in the same quarter of 2024 [3]. - The report indicated that pretax income excluding valuation-related items was $47.8 million, reflecting a 70% decrease from the previous quarter, primarily due to increased realization of mortgage servicing rights cash flows driven by lower mortgage rates and higher prepayment activity [3]. - Following the financial report, PennyMac's stock price dropped by $49.78 per share, or 33.3%, closing at $99.92 per share on January 30, 2026 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its success in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased GSI Technology securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GSI Technology [2]. Group 2: Stock Price Impact - Following allegations that GSI Technology may have misrepresented its product capabilities, the company's stock price fell by $1.08 per share, or 14.2%, closing at $6.52 per share on February 4, 2026 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements [4]. - In 2019, the firm secured over $438 million for investors, demonstrating its capability in recovering significant amounts for clients [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Trip.com Group Limited due to allegations of materially misleading business information [1] Group 1: Legal Action and Investor Rights - Investors who purchased Trip.com Group securities may be entitled to compensation through a class action without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 2: Stock Performance and Regulatory Issues - Trip.com stock fell 17% on January 14, 2026, after the company disclosed it is under investigation by China's market regulator for potential antitrust violations [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions for investors over the years [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Smart Digital Group Ltd. (NASDAQ: SDM) between May 5, 2025, and September 26, 2025, of the upcoming lead plaintiff deadline on March 16, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased SDM securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 16, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that during the Class Period, Smart Digital made false and misleading statements and failed to disclose critical information regarding market manipulation and fraudulent promotion schemes [5]. - Specific allegations include the use of offshore accounts for coordinated share dumping, omission of risks related to fraudulent trading, and misleading positive statements about the company's business and prospects [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of PayPal Holdings, Inc. common stock during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and growth projections [1][5]. Group 1: Class Action Details - The class action lawsuit is for investors who purchased PayPal common stock between February 25, 2025, and February 2, 2026, and they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. - Investors wishing to serve as lead plaintiff must file with the Court by April 20, 2026, and a lead plaintiff acts on behalf of other class members in directing the litigation [3][5]. Group 2: Allegations Against PayPal - The lawsuit alleges that PayPal's management provided overly optimistic statements regarding the company's financial targets for 2027 and the growth of its Branded Checkout segment while concealing material adverse facts about the salesforce's capabilities [5]. - It is claimed that the defendants misled investors by presenting a false narrative about the company's readiness to capitalize on growth opportunities, which ultimately led to investor damages when the true state of affairs was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes its experience and success in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of American Depositary Shares (ADS) of Mereo BioPharma Group plc about the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company regarding its clinical studies [1]. Group 1: Class Action Details - Investors who purchased Mereo ADSs between June 5, 2023, and December 26, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 6, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements in securities class action settlements, including a notable settlement against a Chinese company and ranking highly in the number of settlements since 2013 [4]. Group 3: Case Background - The lawsuit alleges that Mereo BioPharma provided investors with misleading information regarding the expected results of its Phase 3 clinical studies for setrusumab in treating Osteogenesis Imperfecta [5]. - Defendants are accused of making positive statements about the drug's efficacy while concealing adverse facts about the studies, which ultimately did not meet their primary endpoints [6].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of securities of Franklin BSP Realty Trust, Inc. for the period between November 5, 2024, and February 11, 2026, due to alleged misleading statements regarding the company's prospects and dividend maintenance [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that defendants made false and/or misleading statements about Franklin BSP Realty Trust's business and operations, including overstating its prospects and ability to maintain a $0.355 dividend [5]. - Investors who purchased securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by April 27, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Inovio Pharmaceuticals, Inc. securities between October 10, 2023, and December 26, 2025, of the April 7, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Inovio securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by April 7, 2026, to serve as lead plaintiff [2] - The lead plaintiff acts on behalf of other class members in directing the litigation [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for securities class action settlements since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3] Group 3: Case Allegations - The lawsuit alleges that Inovio made false and misleading statements regarding the manufacturing of its CELLECTRA device and the likelihood of submitting the INO-3107 Biologics License Application to the FDA by the second half of 2024 [4] - It is claimed that Inovio lacked sufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review, leading to overstated regulatory and commercial prospects [4] - The lawsuit asserts that when the true details became known, investors suffered damages due to the misleading public statements made by the defendants [4]